MARK1 and gastric cancer: Additionally, our data have demonstrated that BI could inhibit the activity of COX-2 [14] to suppress proliferation of breast cancer cell, through the MARK pathway in gastric cancer cells to arrest the cell cycle [12], and inhibit the PI3K - AKT pathway to trigger apoptosis of gastric cancer cells [22].